ArticleJournal for immunotherapy of cancer2025

CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy.

Regina M Myers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.